Brief: Alkermes Reports Receipt Of Notices Of Partial Termination From Janssen Pharmaceutica

Alkermes

08/11/2021 21:53

Nov 8 (Reuters) - Alkermes Plc  ALKS.O :
    * ALKERMES ANNOUNCES RECEIPT OF NOTICES OF PARTIAL
TERMINATION
FROM JANSSEN PHARMACEUTICA
    * ALKERMES- TERMINATIONS IMPACT KNOW-HOW ROYALTIES RELATED
TO
SALES OF LONG-ACTING PALIPERIDONE PRODUCTS,  AND OTHER PRODUCTS
IN UNITED STATES
    * PURSUANT TO AGREEMENTS, PARTIAL TERMINATION IS TO BECOME
EFFECTIVE THREE MONTHS FROM DATE OF RECEIPT OF NOTICES
    * JANSSEN MAINTAINS THAT IT HAS NOT UTILIZED, AND DOES NOT
UTILIZE, ALKERMES' NANOCRYSTAL TECHNOLOGY LICENSED UNDER
AGREEMENTS

Source text for Eikon:  ID:nPreNL7V7a 
Further company coverage:  ALKS.O 

 ((Reuters.Briefs@thomsonreuters.com;))